BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12820447)

  • 1. Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma.
    Murata K; Shiraki K; Kawakita T; Yamamoto N; Okano H; Nakamura M; Sakai T; Deguchi M; Ohmori S; Nakano T
    Anticancer Res; 2003; 23(2C):1719-22. PubMed ID: 12820447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous arterial infusion of low-dose cisplatin, 5-fluorouracil as adjuvant therapy in cytoreductive surgery for advanced hepatocellular carcinoma].
    Ogata T; Okuda K; Tanaka S; Shibata J; Koga A; Kinoshita H; Nakayama T; Aoyagi S; Tanaka M; Tanikawa K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1661-4. PubMed ID: 9382501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein.
    Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K
    J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T; Mimura T; Tutui N
    J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
    Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of continuous arterial infusion chemotherapy with CDDP and 5-FU in patients with hepatocellular carcinoma].
    Yanagi I; Koga A; Okuda K; Aso K; Nishio T; Shirotani T; Kodama T; So H; Shibata J; Nagashima J
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1508-10. PubMed ID: 7574745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Takeda Y; Hasuike Y; Tsujinaka T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1712-7. PubMed ID: 11708016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic arterial infusion chemotherapy using totally implantable port system].
    Takayasu Y; Yamamoto S; Ikeda J
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of continuous arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with hepatocellular carcinoma].
    Takao T; Nisida M; Maeda Y; Mori N; Tamesa T; Tangoku A; Oka M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1836-40. PubMed ID: 10560407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of hepatocellular carcinoma treated by intra-arterial infusion chemotherapy using THP-adriamycin].
    Sunahara M; Une Y; Sato Y; Nagabuchi E; Misawa K; Uchino J
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1201-4. PubMed ID: 8751811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
    Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of continuous local arterial-infusion chemotherapy for severely advanced hepatocellular carcinoma (HCC) using reservoir].
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Suga T; Itobayashi E; Shimauchi A
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1769-74. PubMed ID: 8397488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study of continuous infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with primary liver cancer].
    Takao T; Nishida M; Maeda Y; Takao K; Oka M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1724-7. PubMed ID: 9382516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of continuous arterial infusion chemotherapy with 5-FU and CDDP in patients with hepatocellular carcinoma].
    Yanagi I; Koga A; Aso K; Shirotani T; Komesu I; Okuda K; Ohgami N; Sou H; Shibata J; Kumabe T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2207-10. PubMed ID: 7944441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.